Paper42439705
Urinary Profiles of Exosomal LINE-1 mRNA and Associated miRNAs in Non-Small-Cell Lung Cancer.
Hassanin AAI and 1 other. Cells, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Urinary Profiles of Exosomal LINE-1 mRNA and Associated miRNAs in Non-Small-Cell Lung Cancer. Papers, record 42439705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42439705
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Urinary Profiles of Exosomal LINE-1 mRNA and Associated miRNAs in Non-Small-Cell Lung Cancer.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Non-Small-Cell Lung | Major topic |
| MicroRNAs | Major topic |
| Exosomes | Major topic |
| Lung Neoplasms | Major topic |
| RNA, Messenger | Major topic |
| Long Interspersed Nucleotide Elements | Major topic |
| Humans | |
| Female | |
| Male | |
| Biomarkers, Tumor | |
| Middle Aged | |
| Gene Expression Regulation, Neoplastic | |
| Aged |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 ES034542 | NIEHS NIH HHS | United States | R01ES034542 | PubMed | NIH RePORTER |
| 1R01ES034542-34 | NIH HHS | United States | R01ES034542 | PubMed | NIH RePORTER |
| N/A | a Governor's University Research Initiative | PubMed | PubMed | ||
| RP230204 | Cancer Prevention and Research Institute of Texas | PubMed | PubMed |
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24400444 | Epidermal growth factor receptor localized to exosome membranes as a possible biomarker for lung cancer diagnosis. | Pharmazie | 2013 | https://conductscience.org/library/papers/24400444 | PubMed |
| 2 | 8395003 | Synchronous expression of LINE-1 RNA and protein in mouse embryonal carcinoma cells. | Mol Cell Biol | 1993 | https://conductscience.org/library/papers/8395003 | PubMed |
| 3 | 37283359 | miR-21, miR-221, and miR-222 upregulation in lung cancer promotes metastasis by reducing oxidative stress and apoptosis. | Rev Assoc Med Bras (1992) | 2023 | https://conductscience.org/library/papers/37283359 | PubMed |
| 4 | 38256242 | Long Interspersed Nuclear Element-1 Analytes in Extracellular Vesicles as Tools for Molecular Diagnostics of Non-Small Cell Lung Cancer. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38256242 | PubMed |
| 5 | 21300873 | MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21300873 | PubMed |
| 6 | 29293438 | LINE-1-encoded reverse Transcriptase as a target in cancer therapy. | Front Biosci (Landmark Ed) | 2018 | https://conductscience.org/library/papers/29293438 | PubMed |
| 7 | 30454683 | Line-1: Implications in the etiology of cancer, clinical applications, and pharmacologic targets. | Mutat Res Rev Mutat Res | 2018 | https://conductscience.org/library/papers/30454683 | PubMed |
| 8 | 1722352 | Reverse transcriptase encoded by a human transposable element. | Science | 1991 | https://conductscience.org/library/papers/1722352 | PubMed |
| 9 | 36229645 | Evaluation of circulating small extracellular vesicle-derived miRNAs as diagnostic biomarkers for differentiating between different pathological types of early lung cancer. | Sci Rep | 2022 | https://conductscience.org/library/papers/36229645 | PubMed |
| 10 | 42303974 | The IKKα-regulated microRNA miR-9-5p mediates lung cancer growth and invasiveness via CDH1/Wnt/β-catenin signalling. | Cell Death Discov | 2026 | https://conductscience.org/library/papers/42303974 | PubMed |
| 11 | 21744498 | A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. | EMBO Mol Med | 2011 | https://conductscience.org/library/papers/21744498 | PubMed |
| 12 | 28188229 | The Human Long Interspersed Element-1 Retrotransposon: An Emerging Biomarker of Neoplasia. | Clin Chem | 2017 | https://conductscience.org/library/papers/28188229 | PubMed |
| 13 | 27253694 | Cancer treatment and survivorship statistics, 2016. | CA Cancer J Clin | 2016 | https://conductscience.org/library/papers/27253694 | PubMed |
| 14 | 31468250 | Let-7 as biomarker, prognostic indicator, and therapy for precision medicine in cancer. | Clin Transl Med | 2019 | https://conductscience.org/library/papers/31468250 | PubMed |
| 15 | 31448067 | Extracellular vesicles mediate the horizontal transfer of an active LINE-1 retrotransposon. | J Extracell Vesicles | 2019 | https://conductscience.org/library/papers/31448067 | PubMed |
| 16 | 34723712 | miR-9-5p Promotes Lung Adenocarcinoma Cell Proliferation, Migration and Invasion by Targeting ID4. | Technol Cancer Res Treat | 2021 | https://conductscience.org/library/papers/34723712 | PubMed |
| 17 | 21116241 | Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. | Lab Invest | 2011 | https://conductscience.org/library/papers/21116241 | PubMed |
| 18 | 31155338 | Abandoning the Notion of Non-Small Cell Lung Cancer. | Trends Mol Med | 2019 | https://conductscience.org/library/papers/31155338 | PubMed |
| 19 | 41221149 | Exosomal Long Interspersed Nuclear Element-1 Analytes Discriminate Histologic Subtypes, Sex, and Clinicopathological Characteristics of Patients with Non-Small Cell Lung Cancer. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/41221149 | PubMed |
| 20 | 27651444 | Epigenetic Signatures of Cigarette Smoking. | Circ Cardiovasc Genet | 2016 | https://conductscience.org/library/papers/27651444 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42923287 | Research progress and clinical translation prospects of multiple urinary biomarkers in non-invasive diagnosis of urothelial carcinoma. | Front Oncol | 2026 | https://conductscience.org/library/papers/42923287 |
Source PubMed
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MIR1263 | 100302148 | PubTator's text mining | https://conductscience.org/library/genes/100302148 | NCBI Gene |
| MIR215 | 406997 | PubTator's text mining | https://conductscience.org/library/genes/406997 | NCBI Gene |
| MIR95 | 407052 | PubTator's text mining | https://conductscience.org/library/genes/407052 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42439705
GET https://conductscience.org/api/papers/v1/42439705/references?page=2